What challenge did Orange 142 address for the pharma brand?

Orange 142 was tasked with proving that integrating healthcare provider (HCP) and direct-to-consumer (patient) digital campaigns could significantly and positively impact script writing behaviors for a large pharma brand.

What was the main outcome of the unified campaign strategy?

The unified healthcare provider and patient campaigns boosted the TRx and NRx prescribing rate by 25% for the top pharma brand. This demonstrated a significant impact on overall script lift and new prescriptions filled.

How did Orange 142 achieve these results?

Orange 142 delivered results through an integrated performance strategy, precise and high-performing audience targeting, and by acting as a top partner, leveraging outcome data to coordinate campaigns effectively.

Unified Healthcare Provider & Patient Campaigns Boost Script Lift by 25% for Top Pharma Brand

0:53

A large pharma brand asked us to prove that integrating healthcare provider (HCP) and direct-to-consumer (patient) digital campaigns results in a significant and positive impact on script writing behaviors.

Our strategy was to create a case-match control study that leveraged outcome data to coordinate HCP and patient campaigns, measuring the combined effect of HCP and patient marketing on total scripts and new prescriptions filled.

Curated Audience Active Reach
7,900 HCPs
Target List Active Reach
7,956 HCPs